Quantcast
Home > Quotes > SGMO
SGMO

Sangamo Therapeutics, Inc. Common Stock (SGMO) Quote & Summary Data

$11.07
*  
0.52
4.93%
Get SGMO Alerts
*Delayed - data as of Nov. 21, 2018 11:43 ET  -  Find a broker to begin trading SGMO now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    SGMO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 11.07 / $ 11.10
1 Year Target
25
Today's High / Low
$ 11.13 / $ 10.60
Share Volume
299,928
50 Day Avg. Daily Volume
1,925,406
Previous Close
$ 10.55
52 Week High / Low
$ 27.50 / $ 9
Market Cap
1,130,167,993
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -0.68
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.84

Intraday Chart

Shares Traded

Share Volume:
299,928
50 Day Avg. Daily Volume:
1,925,406

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.68

Trading Range

The current last sale of $11.07 is 23.00% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 11.13 $ 27.50
 Low: $ 10.60 $ 9

Company Description (as filed with the SEC)

We are a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients' lives using our industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. We are a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. We have used our knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation.  ... More ...  


Risk Grade

Where does SGMO fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 10.72
Open Date:
Nov. 21, 2018
Close Price:
N/A
Close Date:
N/A

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x